Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Inventiva publie ses informations financières du 3ème trimestre 2024¹ Trésorerie et équivalents de trésorerie à 13,9 millions d’euros au 30 septembre 2023.Chiffre d’affaires de 1,3 millions...
Cash and cash equivalents at €13.9 million, as of September 30, 2024.Revenues of €1.3 million for the first nine months of 2024.On July 18, 2024, Inventiva issued royalty certificates for an...
Inventiva reports 2024 Third Quarter Financial Information¹ Cash and cash equivalents at €13.9 million, as of September 30, 2024.Revenues of €1.3 million for the first nine months of 2024.On July...
Information relative au nombre total de droits de vote et d’actions composant le capital social au 4 novembre 2024 Article R. 22-10-23 du Code de commerce Place de cotation : Euronext ParisCode...
Statement of total voting rights and shares forming the company’s share capital as of November 4, 2024 Article R. 22-10-23 of the French Commercial Code Market : Euronext ParisISIN code /...
Combined General Meeting of December 11, 2024 - Availability of the preparatory documents Daix (France), Long Island City (New York, United States), November 20, 2024 – Inventiva (Euronext Paris...
Assemblée Générale Mixte du 11 décembre 2024 - Modalités de mise à disposition des documents préparatoires Daix (France), Long Island City (New York, Etats-Unis), le 20 novembre 2024 – Inventiva...
Daix (France), Long Island City (New York, United States), November 20, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of...
Inventiva présentera lors de la session « late-breaker » de l'AASLD The Liver Meeting®, les résultats de l'analyse finale de la Phase 2 évaluant la combinaison de lanifibranor avec...
Data will be presented on Monday, November 18th as a late breaker poster at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2024 in San Diego.LEGEND achieved...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.155 | -5.96153846154 | 2.6 | 2.63 | 2.36 | 19918 | 2.52464023 | DE |
| 4 | 0.005 | 0.204918032787 | 2.44 | 2.635 | 2.31 | 21622 | 2.49602498 | DE |
| 12 | 0.25 | 11.3895216401 | 2.195 | 3.2 | 1.434 | 56722 | 2.28842362 | DE |
| 26 | -1.095 | -30.9322033898 | 3.54 | 3.555 | 1.434 | 44432 | 2.43387002 | DE |
| 52 | -1.195 | -32.8296703297 | 3.64 | 4.44 | 1.434 | 49938 | 3.01995876 | DE |
| 156 | -9.115 | -78.8494809689 | 11.56 | 12.7 | 1.434 | 53582 | 3.97031796 | DE |
| 260 | -0.355 | -12.6785714286 | 2.8 | 16.3 | 1.434 | 64154 | 7.05552979 | DE |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
